Guidance for Organ Donation and Transplantation Professionals Regarding the Zika Virus
Published 4 February 2016
UNOS; Feb 2016.
Zika virus is a flavivirus transmitted by Aedes (Stegomyia) mosquitoes, most commonly by A. aegypti. Zika virus has been recognized in Brazil since 2014, and local transmission now has been reported in more than 20 countries and territories in the Western Hemisphere, including South America, Central America, Mexico, and the Caribbean.
The OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC), the American Society of Transplantation (AST), and the American Society of Transplant Surgeons (ASTS), after careful review of information available from the Centers for Disease Control and Prevention (CDC), offers this information to transplant centers and Organ Procurement Organizations (OPOs) in light of recent spread of Zika virus throughout large parts of the Americas.
Read at UNOSRelated Guidlines
-
HFSA/SAEM/ISHLT Clinical Expert Consensus Document on the Emergency Management of Patients with Ventricular Assist Devices
-
ISHLT Consensus Statement on Adult and Pediatric Airway Complications after Lung Transplantation
-
Chronic Lung Allograft Dysfunction: Definition, Diagnostic Criteria, and Approaches to Treatment
-
Generic Drug Immunosuppression in Thoracic Transplantation
-
ISHLT Consensus Statement for the Standardization of Bronchoalveolar Lavage in Lung Transplantation